Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

Molecular Pain

Open Access

Sphingosine 1-phosphate to p38 signaling via S1P1 receptor and Gαi/o evokes augmentation of capsaicin-induced ionic currents in mouse sensory neurons

  • Michiel Langeslag1Email author,
  • Serena Quarta1,
  • Michael G Leitner2,
  • Michaela Kress1 and
  • Norbert Mair1
Molecular Pain201410:74

https://doi.org/10.1186/1744-8069-10-74

Received: 8 July 2014

Accepted: 3 November 2014

Published: 28 November 2014

Abstract

The perception of painful thermal stimuli by sensory neurons is largely mediated by TRPV1. Upon tissue injury or inflammation, S1P is secreted by thrombocytes as part of an inflammatory cocktail, which sensitizes nociceptive neurons towards thermal stimuli. S1P acts on G-protein coupled receptors that are expressed in sensory neurons and sensitize TRPV1 channels towards thermal stimuli. In this study, the S1P mediated signaling pathway required for sensitization of TRPV1 channels was explored.

The capsaicin induced peak inward current (ICAPS) of sensory neurons was significantly increased after S1P stimulation within minutes after application. The potentiation of ICAPS resulted from activation of Gαi through G-protein coupled receptors for S1P. Consequently, Gαi led to a signaling cascade, involving phosphoinositide-3-kinase (PI3K) and protein kinase C, which augmented ICAPS in nociceptive neurons. The S1P1 receptor agonist SEW2871 resulted in activation of the same signaling pathway and potentiation of ICAPS. Furthermore, the mitogen-activated protein kinase p38 was phosphorylated after S1P stimulation and inhibition of p38 signaling by SB203580 prevented the S1P-induced ICAPS potentiation. The current data suggest that S1P sensitized ICAPS through G-protein coupled S1P1 receptor activation of Gαi-PI3K-PKC-p38 signaling pathway in sensory neurons.

Keywords

Sphingosine 1-phosphateTRPV1CapsaicinGαiPhosphoinositide 3-kinaseMAP-kinase p38

Background

The perception of pain is mediated by nociceptive primary afferent neurons that are excited upon painful thermal, mechanical or chemical stimuli [1]. These nociceptive neurons demonstrate increased sensitivity towards painful stimuli during inflammation or injury when challenged by pro-inflammatory mediators (e.g. bradykinin, prostaglandin) [2, 3]. The cellular and molecular mechanisms that are involved in thermal pain perception and sensitization are well studied and comprise many different signaling pathways and proteins [4, 5].

The perception of heat involves members of the transient receptor potential (TRP) ion channels, more specifically members of the vanilloid subfamily (TRPV). In particular activation of TRPV1 ion channels results in the excitation of nociceptors and consequently the perception of pain [6, 7]. TRPV1 is a non-specific cation channel that is not only activated by heat but also by vanilloid agonists like capsaicin and resiniferatoxin, by low pH (<5.5) and various lipids [8, 9]. The activation of TRPV1 ion channels results in opening of the channel and subsequent membrane depolarization of nociceptive neurons.

In the presence of inflammatory mediators, the threshold temperature at which TRPV1 channels are activated is decreased and nociceptive neurons respond to thermal stimuli at lower temperatures and with an augmented response. The regulation of TRPV1 by inflammatory mediators released by the immune system receives extensive attention since it is clinically relevant for developing pathological and chronic pain. Activation of G-protein coupled or tyrosine kinase receptors modulate TRPV1 ion channel activity via various intracellular signaling pathways [10, 11].

Tissue damage that usually coincides with damage to the blood vessels results in tissue invasion of different cells of the immune system together with thrombocytes. At the injury site, thrombocytes are activated and secrete a variety of immunomodulatory compounds including the sphingolipid sphingosine 1-phosphate (S1P). S1P can activate signaling pathways either through diffusion over the plasmamembrane or through binding to S1P specific receptors (S1P1–5) at the plasmamembrane.

After binding of S1P to its specific receptors, activation of the receptor subtype determines the heteromeric G-protein signaling pathway. For example, the S1P1 receptor solely signals through Gαi-proteins whereas the S1P3 receptor can activate Gαi, Gαq and/or Gα12/13 signaling pathways. Through this pleiotropic activation, S1P can exert its effects on various signaling pathways involving e.g. Rho, PLC, p38 and ERK (p42/44) signaling [12]. Previously we have shown that nociceptors primarily express S1P1 and S1P3 receptors whereas the larger NF200-positive cells express S1P2 receptors. Recently it has been found that S1P enhances neuron excitability [13, 14] and sensitizes dorsal root ganglion (DRG) neurons to heat [15].

Converging evidence from pharmacological and genetic models suggests that the S1P1 receptor is a main contributor to S1P-induced hyperexcitability and heat sensitization in mouse nociceptors [1416]. Although S1P1 receptor signaling is restricted to Gαi-mediated signal transduction, the molecular players of TRPV1 mediated sensitization by S1P remain unclear. Here we explore the S1P-PI3K-p38 signaling pathway in sensory neurons for the potentiation of capsaicin-induced, excitatory inward currents.

Results

S1P-induced potentiation of capsaicin-activated excitatory inward currents

In humans and mice, the bio-active lipid S1P evokes spontaneous pain behavior [17]. Besides, intradermal injection of S1P in the hindpaw of mice induces heat-hypersensitivity as indicated by reduction of reflex paw withdrawal latencies in response to radiant heat stimulation [15]. Responses of nociceptive neurons to heat are mainly mediated by the transient receptor potential vanilloid receptor TRPV1 that is essential for the development of thermal hypersensitivity [6, 18, 19]. To assess TRPV1 function we performed whole-cell recordings of capsaicin-evoked excitatory inward currents (ICAPS, 0.3 μM capsaicin) from neurons isolated from mouse dorsal root ganglia (DRG). Application of S1P (1.0 μM, 60s) caused a significant increase of ICAPS peak amplitudes (fold increase: 3.22 ± 0.81, n = 18, p < 0.001, Figure  1A,B). The potentiation of ICAPS was transient and fully recovered within 6 minutes, suggesting a modification of ion channel function as underlying mechanism. Repetitive application of capsaicin did not result in potentiation of the inward current in DRG neurons for the first five to six applications (Figure  1C) and obviously was prone to desensitization at later time points.
Figure 1

S1P potentiates capsaicin-induced currents in cultured DRG sensory neurons. A, a typical voltage-clamp recording from a DRG neuron that is repetitively stimulated with capsaicin (0.3 μM white and grey triangles). Between the 3rd and 4th capsaicin application DRG neurons were stimulated with 1.0 μM S1P (green bar) that resulted in augmentation of ICAPS (grey triangles). The dashed line represents 0 nA. B, Quantification of S1P induced potentiation of ICAPS, which were normalized to amplitude of the 3rd ICAPS, showed that S1P potently increased ICAPS up to 4 minutes after S1P application. ***p < 0.001, *p < 0.05, MWU-test. C, Repetitive application of capsaicin did not result in potentiation of ICAPS. Numbers within the bars represent the number of individual recorded.

To explore whether S1P potentiated capsaicin induced currents through G-protein coupled receptors (GPCR) activation or rather by direct activation of the channel. In the presence of extracellular suramin (100 μM), which is generally accepted to uncouple heteromeric G-proteins from their ligand-binding receptor subunit, S1P failed to evoke an increase in ICAPS (see Additional file 1). To more specifically prevent G-protein mediated signaling, GDPβS (3.0 mM) was included in the intracellular solution. In nociceptive neurons treated with GDPβS, S1P no longer induced an increase in ICAPS (Figure  2A). Therefore it is concluded that S1P acted on a G-protein coupled receptor (GPCR) to regulate TRPV1-induced currents.
Figure 2

Inhibition of downstream signaling mediated by S1P largely prevents potentiation of I CAPS in sensory neurons. A, inhibition of heteromeric G-proteins by inclusion of 3.0 mM GDPβS in the patch pipette fully prevented the potentiation of ICAPS mediated by 1.0 μM S1P. Furthermore, inhibition of Gαi by pertussis toxin (100 ng/ml PTX, B), PI3Kγ (100nM AS605240, C) and PKC (1.0 μM BIM-1, D) decreased the amplitude of S1P mediated ICAPS potentiation in sensory nociceptors significantly compared to the enhanced ICAPS after S1P stimulation (E). ***p < 0.001, **p < 0.01, *p < 0.05, MWU-test, numbers within the bars represent the number of individual cells recorded.

S1P potentiates ICAPS via Gαi-PI3K-PKC signaling cascade

Whereas S1P2 and S1P3 receptors couple to all three G-protein types [20, 21], S1P1 exclusively couples to Gαi/o and no activation of other heteromeric G-proteins has been reported to date [22, 23]. We therefore pretreated sensory neurons for 20 hours with the Gαi/o-selective inhibitor pertussis toxin (PTX; 100 ng/ml). The potentiation of ICAPS after conditioning stimulation with S1P was reduced by pretreatment with PTX in the patch-clamp recordings, suggesting the involvement of Gαi/o heteromeric G-proteins in the signaling process (Figure  2B). It is generally accepted that activation of Gαi/o α-subunit inhibits the adenylyl cyclase/protein kinase A (PKA) pathway. Since TRPV1 activity is upregulated via PKA mediated phosphorylation, a S1P-dependent reduction of PKA activity should attenuate heat responses in sensory neurons [2428]. However, as shown above, S1P1 augmented nociceptor activity in three independent models. This apparent controversy could be explained if S1P activated a sensitizing pathway via β/γ G-protein subunits rather than activation via the α-subunit. Phosphatidyl-inositol-triphosphate kinase (PI3K) isoenzymes have been identified as targets of S1P1 and S1P3 signaling in some studies [2931]. After inhibition of the phosphoinositide kinases PIP4K and PI3K by Wortmannin (1.0 μM, data not shown), S1P did not facilitate ICAPS to the same extent as in control ECS. Selective inhibition of PI3K by AS605240 (100nM), also attenutated S1P potentiation of ICAPSand the inhibition of S1P-induced potentiation of ICAPS by Wortmannin and AS605240 was comparable to the decrease in S1P-mediated TRPV1 potentiation after PTX incubation (Figure  2E).

Since PI3K can activate PKCs [32], pretreatment with the non-selective PKC inhibitor bisindolylmaleimide-1 (BIM-1, 1.0 μM) was used to investigate whether this downstream signaling pathway was involved in S1P induced modification of ICAPS. After inhibition of PKC, ICAPS was still potentiated after conditioning exposure to S1P although the degree of sensitization was significantly reduced. In comparison to the S1P-mediated potentiation, BIM-1 potently attenuated the potentiation of ICAPS induced by S1P in patch-clamp recordings of DRG neurons (Figure  2D,E). The inhibition of S1P-mediated ICAPS potentiation was to the same extent as observed after inhibition of the Gαi and PI3K pathway (Figure  2E).

SEW2871 induced S1P1 receptor activation sensitizes ICAPS

Stimulation of DRG neurons with S1P could activate both S1P1 and S1P3-receptors on the same neuron. The S1P1-receptor expressed on nociceptive neurons has been shown to be the major signaling pathway contributing to heat sensitization and presumably affected nociceptive neurons directly [15]. Previously we have shown that SEW2871, a specific and selective agonist for the S1P1 receptor, also facilitates capsaicin-induced currents [15]. Since S1P1 receptor only signals via Gαi, we used SEW2871 to assess the involvement of the Gαi-signaling pathway in S1P mediated TRPV1 potentiation (Figure  3A). The sensitization of ICAPS by SEW2871 (1.0 μM) was completely inhibited by 20 h pre-incubation with PTX and thus completely relied on the activation of Gαi (Figure  3A,B). In line with earlier findings in this study, inhibition of phophoinositide kinases by Wortmannin or PKCs by BIM-1 fully prevented potentiation of capsaicin-induced inward currents by SEW2871. Accordingly, these data suggested that Gαi-PI3K-PKC signaling was activated through the S1P1 pathway solely, whereas additional S1P receptors might play a minor role in S1P-mediated ICAPS sensitization.
Figure 3

I CAPS sensitization by depends on S1P 1 receptor signaling. A, The enhancement of ICAPS by the S1P1 specific receptor agonist SEW2871 (1.0 μM) was completely inhibited by pertussis toxin (PTX, 100 ng/ml). The dashed line signifies the zero current. B, Moreover, inhibition of the PI3K by Wortmannin (WM, 1.0 μM) and PKC (BIM-1, 1.0 μM) fully prevented the potentiation of ICAPS that was induced by S1P1 receptor activation by SEW2781 (SEW). *p < 0.05, MWU-test, numbers within the bars represent the number of individual cells recorded.

Activation of MAP-kinase p38 by S1P increases ICAPS

S1P receptor signaling pathways activates p38 or p42/44 MAP kinases through phosphorylation [33, 34]. Therefore, the levels of phosphorylated p42/44 and p38 were assessed by Western blot with phosphorylation-specific antibodies and subsequent quantification of the blots. We did not detect significant activation of the MEK/ERK pathway by S1P as the relative amount of p-p42/p44 phosphorylation was not changed (data not shown). Interestingly however, p-p38 levels increased significantly (1.57 ± 0.09, n = 5) following S1P stimulation of neurons cultures, which suggested a major contribution of p38 in the S1P signaling pathway (Figure  4C). The phosphorylation of p38 induced by S1P was completely inhibited by SB203580 (0.97 ± 0.12, n = 4), a specific inhibitor of the p38 signaling pathway (Figure  4C). In line with this finding, the potentiation of ICAPS evoked by S1P was largely inhibited after pre-incubation with SB203580 (Figure  4A). The ICAPS recorded immediately after S1P stimulation was significantly reduced compared to control conditions (Figure  4B, Ctrl; 3.22 ± 0.81 vs. SB203850; 1.59 ± 0.30, p < 0.01, MWU). Overall, the SB203580-mediated inhibition of the ICAPS potentiation was similar to the application of by PTX, AS605240 and BIM-1.
Figure 4

Activation of p38 is critical in the S1P induced I CAPS potentiation in sensory neurons. A, In a typical current recording of a nociceptor, the ICAPS increase caused by 1.0 μM S1P stimulation is greatly diminished by inhibition of p38 activation by SB203850 (1.0 μM). Zero current is drawn as dashed line. B, Pretreatment of sensory DRG neurons with SB203850 (1.0 μM) significantly reduced the S1P mediated potentiation of ICAPS. ***p < 0.001, **p < 0.01, MWU-test. C, Western blot analysis of p38 activation (p-p38) showed that S1P significantly increased the p-p38 levels in sensory neurons, whereas SB23850 (SB) reversed the p-p38 levels to control, unstimulated levels. ***p < 0.001, **p < 0.01, ANOVA on Ranks followed by Tukey post-hoc test, numbers within the bars represent the number of individual cells recorded.

Discussion

Our study revealed a prominent role for the S1P1-Gαi-signaling pathway to enhance capsaicin-induced inward currents. This signaling pathway contributed to the S1P induced increase in nociceptors responsiveness to capsaicin and presumably also to thermal stimuli. We characterized the S1P-induced signaling pathway that contributed to enhanced TRPV1 activity and involved a heteromeric Gαi-protein, PI3K, activation of PKC and MAPK p38.

To date, five members of the metabotropic Edg G-protein coupled receptor (GPCR) family are known to specifically bind S1P and to regulate inflammatory and regenerative processes in various systems [35, 36]. Crosstalk of cytokines, growth factors and S1P in inflamed tissue occurs and several reports have addressed the expression of S1P1 and S1P3 receptors in primary afferent nociceptors that sense inflammatory mediators and respond more vigorously to natural stimuli upon inflammation [13, 1517, 37]. Therefore, a major component of nociceptor sensitization that is associated with inflammation could be mediated by S1P acting via S1P1 and/or S1P3 mediated signaling pathways. The widespread expression of S1P3 receptors in all classes of sensory neurons suggests the S1P3 receptor as a candidate to regulate the sensitivity of multiple sensory modalities. Indeed activation of S1P3 receptors in nociceptors induces a pain-like behavior in human and mice. This pain-like behavior is evoked by a membrane depolarization involving S1P3 receptors [17].

A smaller portion of sensory peptidergic and non-peptidergic neurons express S1P1 receptors [15]. S1P induces thermal hypersensitivity in mice and enhances the excitability of sensory neurons [13, 15]. In a transgenic mouse where S1P1 receptors are conditionally ablated in Nav1.8 expressing neurons, the S1P induced heat hypersensitivity is attenuated [15]. In line with these reports, the enhancement of TRPV1 activity following S1P conditioning was mimicked by the S1P1 agonist SEW2871. The augmentation of ICAPS by S1P and SEW2871 was inhibited in the presence of PTX that selectively interferes with the inhibitory G-protein Gαi. This suggests that S1P1 utilizes Gαi for signal transduction in nociceptors, just like in other tissues.

Although the contribution of Gαi to S1P1 receptor signaling is well accepted it is largely unknown which downstream intracellular signaling pathways are activated in nociceptive neurons. In general, the S1P1 receptor has been associated with three different signaling pathways downstream of Gαi-proteins. The classical Gαi signaling involves inhibition of adenylate cyclase and reduction of cyclic AMP levels or inhibition of ERK signaling within the cell [38, 39]. Since cAMP/PKA signaling increases the open probability of TRPV1 ion channels, it can be anticipated that decreased cAMP levels rather leave TRPV1 in a less sensitive state and reduces ICAPS amplitudes which would oppose our findings.

The signaling cascade for S1P induced facilitation of capsaicin-induced currents also differs from the Gαi-mediated activation of ERK1/2 through which S1P1 receptors regulate embryonic self-renewal [40]. TrkA receptor-mediated ERK1/2 acyivation (p42/44) by nerve growth factor induces heat hypersensitivity and potentiates nociceptor responses to capsaicin [4143]. However, ERK1/2 activation was not induced in nociceptive neurons upon S1P stimulation. Therefore the observed enhancement of ICAPS is unlikely to be explained by these two classical Gαi signaling pathways.

An alternative S1P1 signaling pathway involves Gαi-mediated activation of PI3K that has been reported to mediate chemotaxis of natural killer cells [44]. Furthermore PI3K signaling pathways have been associated with the regulation of TRPV1 [45] and increasing evidence suggests that particular isoforms of PI3K signal downstream of GPCRs [46]. In our hands, the potentiation of ICAPS through S1P1 largely depended on PI3K. Thus our results link PI3K as novel component of GPCR signaling for the regulation of nociceptor heat hypersensitivity. Downstream of PI3K several kinases of the mitogen activated protein kinase (MAPK) family can be activated. In particular activation of MAP kinase p38 is strongly associated with Gαi/PI3K signaling through S1P receptors [34, 47]. The MAPK p38 functions as a mediator of cellular stresses such as inflammation and apoptosis [48, 49]. Besides, recent findings showed that activation of p38 contributes to the development and maintenance of both neuropathic and inflammatory pain: For example, in mouse models of neuropathic pain, activation of p38 is observed in microglial cells in the spinal cord and in DRG neurons [5052]. Activation of p38 can have pleiotropic effects within cells, and in sensory neurons it can lead to increased current density of Nav1.8 channels by phosphorylation on short-term [53] and upregulation of Nav1.3 channels on the long-term [54]. The multimodal transducer ion channel TRPV1 is activated by noxious heat and capsaicin the pungent ingredient of hot chili peppers, and it plays a major role in the generation of heat hypersensitivity as occurs as a consequence of tissue inflammation [6, 18, 19, 55]. The sensitivity of TRPV1 to heat and capsaicin depends on the phosphorylation status of the channel at intracellular serine/threonine or tyrosine sites [24, 26, 56]. The degree of serine or threonine phosphorylation at specific consensus sites, e.g. for PKC, regulates the TRPV1 channel activity. Serine phosphorylation determines the open probability of the individual TRPV1 channel complex [8, 10]. Besides, modification at tyrosine residues regulates insertion of preformed TRPV1 complexes into the cellular membrane [43]. Numerous inflammatory mediators including S1P, which target to metabotropic receptors in the nociceptor membrane, are able to facilitate ICAPS either by activating tyrosine kinases or protein kinases A or C. The fast changes in capsaicin sensitivity of the sensory neurons that occurred within 1 minute of S1P stimulation are likely attributable to phosphorylation of the already existing TRPV1 channels in the cell membrane. Some of the phosphorylation sites at intracellular domains of the TRPV1 channel protein do not show preference for PKC, PKA ,or CaMKII (calcium/calmodulin dependent protein kinase II) and could be possible targets for p38 MAP kinase phosphorylation [57]. Although the present experiments and a recent report which links PI3K/p38 and TRPV1 [45] do not unequivocally demonstrate the mutual interdependence of these kinase systems, p38 activation downstream of PI3K is likely and in line with ample evidence from other systems [33, 34, 45, 47].

Therefore we suggest that S1P1 receptor activation and downstream Gαi to PI3K to p38 signaling as important components for the S1P induced nociceptive hypersensitivity towards thermal stimuli. S1P1 to p38 mediated sensitization of TRPV1 may play a role in the early initiation phase of heat hypersensitivity in mice.

Materials and methods

Ethic statement

All animal breeding and experiments have been performed with permission of the Austrian BMWF ministry (BMWF-66.011/0113-II/3b/2010; BMWF-66.011/0051-II/10b2008; GZ 66.011/85-C/GT/2007) and according to ethical guidelines of the IASP (International Association for the Study of Pain).

Primary sensory neuron culture

Lumbar DRG containing the cell bodies of primary afferents that project into the hindpaw were harvested from adult male mice (age 8–16 weeks) as previously published [58, 59]. After removal of the connective tissue, ganglia were incubated in Liberase Blendzyme 1 (9 mg/100 ml DMEM, Roche) for 2 times 30 min. After washing with PBS (PAA), 1× Trypsin-EDTA (Invitrogen) was added for 15 min. and DRG were washed with TNB™ medium (Biochrom) supplemented with L-glutamin (Invitrogen), penicillin G sodium, streptomycin sulfate (Invitrogen), and Protein-Lipid-Komplex™ (Biochrom). The DRG were dissociated with a fire-polished Pasteur pipette and centrifuged through a 3.5% BSA gradient (Sigma) to eliminate non-neuronal cells. The sensory neurons were resuspended, plated on coverslips coated with poly-L-Lysine/laminin-1 (Sigma), and cultivated in supplemented TNB™ containing mNGF 2.5S (Alomone Labs, 10 μg/100 ml TNB-medium) at 37 °C in 5% CO2 for 24–36 h.

Patch-clamp recordings

Using the whole-cell voltage-clamp configuration of the patch-clamp technique, ionic currents were recorded from isolated neurons at -80 mV holding potential after 18–32 hours as previously published [15, 58]. The external solution (ECS) contained (in mM): 145 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2 (all Sigma), 10 glucose and 10 HEPES (Merck, Darmstadt, Germany), at pH 7.3 adjusted with NaOH (Merck). Borosilicate glass micropipettes (Science Products, Hofheim, Germany) pulled with a horizontal puller (Sutter Instruments Company, Novato, CA, USA) were filled with internal solution (ICS, in mM): 148 KCl, 2 MgCl2, 2 Na-ATP, 0.2 Na-GTP, 0.1 CaCl2, 1 EGTA (all Sigma) and 10 HEPES (Merck), at pH 7.3 adjusted with KOH (Merck). After filling, electrode resistance was 4–6 MΩ. Currents were filtered at 2.9 kHz, sampled at 3 kHz and recorded using an EPC-9 (HEKA, Germany) and the Pulse v8.74 software (HEKA) without Rs compensation. Experiments were performed at room temperature and only one neuron was tested per Petri dish. An automated seven-barrel system with common outlet positioned at 100 μm distance from the recorded cell was used for fast drug administration [15]. S1P (1.0 μM) was used as intermittent conditioning stimuli (60s). S1P, capsaicin, PTX and GDPβS were purchased from Sigma Aldrich. All other chemicals were purchased from Merck-Calbiochem.

Western blot

Sensory neurons were plated on poly-L-lysine/laminin-coated dishes, kept in culture for 24 h and stimulated with 1.0 μM S1P for 5 minutes in ECS or 30 minute pre-treated with 1.0 μM p38 inhibitor SB203580 before S1P stimulation. Cells were harvested in freshly prepared, ice-cold lysis RIPA-buffer (50 mM Tris–HCl, 150 mM NaCl, 50 mM NaF, 5 mM EDTA, 0.5% Deoxycholic Acid, 0.1% SDS, 1% Nonidet P-40, all Sigma). The phosphatase inhibitors sodium-orthovanadate (200 μM) and β-glycerophosphate (40 mM, both Sigma) were added to the RIPA buffer to prevent protein dephosphorylation. A protease-inhibitor cocktail (1:10, Sigma) was used to protect proteins from proteolysis. SDS-PAGE was performed under standard denaturing conditions using hand casted 10% polyacrylamide gels (Mini-PROTEAN, Bio-Rad Laboratories). Equal amounts of protein were loaded to each lane of the gels. Spectra Multicolor Broad Range Protein Ladder (Fermentas) was used as a molecular weight standard. Gels were blotted immediately after electrophoresis onto polyvinylidene fluoride membrane (Hybond-P, GE Healthcare). For immunodetection, membranes were blocked for 1 h with 5% (w/v) BSA and 0.1% (v/v) Tween-20 in Tris-buffered saline, pH 7.6, at room temperature. Antibodies were used according to the manufacturer’s instructions. The following antibodies were used: anti-phospho-p38 and anti-p38 (all Cell Signaling Technology) and peroxidase-conjugated α-rabbit IgG (1:5000; Pierce) as secondary antibody. Visualization of blots was performed with enhanced chemiluminescence by using the SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific). Membranes were scanned with LAS4000 luminescent imager (GE Healthcare). Quantification was performed using ImageJ software and relative values for phosphorylated proteins are represented as units after normalization to the non-phosphorylated form.

Statistical analysis

Data are presented as mean ± SEM. For detailed statistical analysis the Sigmastat 3.0 (Aspire Software International) software package was used and Mann Whitney-U test (MWU) or ANOVA on Ranks followed by Tukey post-hoc test were calculated. Differences were considered statistically significant at p < 0.05.

Abbreviations

S1P: 

Sphingosine 1-phosphate

TRPV1: 

Transient receptor potential vanilloid 1

DRG: 

Dorsal root ganglia

ICAPS

Capsaicin-activated inward current

PI3K: 

Phosphatidylinositol-3-kinase

PKC: 

Protein kinase C

MAPK: 

Mitogen activated protein kinase

GPCR: 

G-protein coupled receptor

GDPβS: 

Guanosine 5′-[β-thio]diphosphate

PTX: 

Pertussis toxin

PKA: 

Protein kinase A

ECS: 

Extracellular solution

ICS: 

Intracellular solution

PBS: 

Phosphate buffered saline

DMEM: 

Dulbecco’s modfified Eagle medium

BSA: 

Bovine serum albumin.

Declarations

Acknowledgements

We want to thank Kathrin Braun and Theresa Martha for preparing all the primary sensory neuron cultures. Further we want acknowledge Markus Doblander for assisting in breeding and genotyping of the mice. This project was supported by grants from Austrian Science Fund (FWF): project numbers, P20562 and P25345.

Authors’ Affiliations

(1)
Division Physiology, DPMP, Medical University Innsbruck
(2)
Department of Neurophysiology, Institute for Physiology and Pathophysiology, Philipps University of Marburg

References

  1. Hunt SP, Mantyh PW: The molecular dynamics of pain control. Nat Rev Neurosci 2001, 2: 83–91.PubMedView ArticleGoogle Scholar
  2. Ma C, Greenquist KW, Lamotte RH: Inflammatory mediators enhance the excitability of chronically compressed dorsal root ganglion neurons. J Neurophysiol 2006, 95: 2098–2107.PubMedView ArticleGoogle Scholar
  3. Marchand F, Perretti M, McMahon SB: Role of the immune system in chronic pain. Nat Rev Neurosci 2005, 6: 521–532.PubMedView ArticleGoogle Scholar
  4. Basbaum AI, Bautista DM, Scherrer G, Julius D: Cellular and molecular mechanisms of pain. Cell 2009, 139: 267–284. 10.1016/j.cell.2009.09.028PubMed CentralPubMedView ArticleGoogle Scholar
  5. Foulkes T, Wood JN: Pain genes. PLoS Genet 2008, 4: e1000086. 10.1371/journal.pgen.1000086PubMed CentralPubMedView ArticleGoogle Scholar
  6. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389: 816–824. 10.1038/39807PubMedView ArticleGoogle Scholar
  7. McKemy DD: A spicy family tree: TRPV1 and its thermoceptive and nociceptive lineage. EMBO J 2011, 30: 453–455. 10.1038/emboj.2010.350PubMed CentralPubMedView ArticleGoogle Scholar
  8. Tominaga M, Tominaga T: Structure and function of TRPV1. Pflugers Arch 2005, 451: 143–150. 10.1007/s00424-005-1457-8PubMedView ArticleGoogle Scholar
  9. Vennekens R, Owsianik G, Nilius B: Vanilloid transient receptor potential cation channels: an overview. Curr Pharm Des 2008, 14: 18–31. 10.2174/138161208783330763PubMedView ArticleGoogle Scholar
  10. Vellani V, Mapplebeck S, Moriondo A, Davis JB, McNaughton PA: Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J Physiol 2001,534(Pt 3):813–825.PubMed CentralPubMedView ArticleGoogle Scholar
  11. Zhang H, Cang C, Kawasaki Y, Liang L, Zhang Y, Ji R, Zhao Z-Q: Neurokinin-1 receptor enhances TRPV1 activity in primary sensory neurons via PKCepsilon: a novel pathway for heat hyperalgesia. J Neurosci 2007, 27: 12067–12077. 10.1523/JNEUROSCI.0496-07.2007PubMedView ArticleGoogle Scholar
  12. Obinata H, Hla T: Sphingosine 1-phosphate in coagulation and inflammation. Semin Immunopathol 2012, 34: 73–91. 10.1007/s00281-011-0287-3PubMed CentralPubMedView ArticleGoogle Scholar
  13. Chi XX, Nicol GD: The sphingosine 1-phosphate receptor, S1PR 1 , plays a prominent but not exclusive role in enhancing the excitability of sensory neurons. J Neurophysiol 2010, 104: 2741–2748. 10.1152/jn.00709.2010PubMed CentralPubMedView ArticleGoogle Scholar
  14. Xie W, Strong JA, Kays J, Nicol GD, Zhang J: Knockdown of the sphingosine-1-phosphate receptor S1PR1 reduces pain behaviors induced by local inflammation of the rat sensory ganglion. Neurosci Lett 2012, 515: 61–65. 10.1016/j.neulet.2012.03.019PubMed CentralPubMedView ArticleGoogle Scholar
  15. Mair N, Benetti C, Andratsch M, Leitner MG, Constantin CE, Camprubí-Robles M, Quarta S, Biasio W, Kuner R, Gibbins IL, Kress M, Haberberger RV: Genetic evidence for involvement of neuronally expressed S1P 1 receptor in nociceptor sensitization and inflammatory pain. PLoS One 2011, 6: e17268. 10.1371/journal.pone.0017268PubMed CentralPubMedView ArticleGoogle Scholar
  16. Zhang YH, Fehrenbacher JC, Vasko MR, Nicol GD: Sphingosine-1-phosphate via activation of a G-protein-coupled receptor(s) enhances the excitability of rat sensory neurons. J Neurophysiol 2006, 96: 1042–1052. 10.1152/jn.00120.2006PubMedView ArticleGoogle Scholar
  17. Camprubí-Robles M, Mair N, Andratsch M, Benetti C, Beroukas D, Rukwied R, Langeslag M, Proia RL, Schmelz M, Ferrer Montiel AV, Haberberger RV, Kress M: Sphingosine-1-phosphate-induced nociceptor excitation and ongoing pain behavior in mice and humans is largely mediated by S1P3 receptor. J Neurosci 2013, 33: 2582–2592. 10.1523/JNEUROSCI.4479-12.2013PubMedView ArticleGoogle Scholar
  18. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D: Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288: 306–313. 10.1126/science.288.5464.306PubMedView ArticleGoogle Scholar
  19. Davis JB, Gray J, Gunthorpe MJ, Hatcher JP, Davey PT, Overend P, Harries MH, Latcham J, Clapham C, Atkinson K, Hughes SA, Rance K, Grau E, Harper AJ, Pugh PL, Rogers DC, Bingham S, Randall A, Sheardown SA: Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 2000, 405: 183–187. 10.1038/35012076PubMedView ArticleGoogle Scholar
  20. Anliker B, Chun J: Cell surface receptors in lysophospholipid signaling. Semin Cell Dev Biol 2004, 15: 457–465. 10.1016/j.semcdb.2004.05.005PubMedView ArticleGoogle Scholar
  21. Ishii I, Fukushima N, Ye X, Chun J: Lysophospholipid receptors: signaling and biology. Annu Rev Biochem 2004, 73: 321–354. 10.1146/annurev.biochem.73.011303.073731PubMedView ArticleGoogle Scholar
  22. Young N, Van Brocklyn JR: Signal transduction of sphingosine-1-phosphate G protein-coupled receptors. ScientificWorldJournal 2006, 6: 946–966.PubMedView ArticleGoogle Scholar
  23. Takabe K, Paugh SW, Milstien S, Spiegel S: "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev 2008, 60: 181–195. 10.1124/pr.107.07113PubMed CentralPubMedView ArticleGoogle Scholar
  24. Bhave G, Hu H-J, Glauner KS, Zhu W, Wang H, Brasier DJ, Oxford GS, Gereau RW: Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Proc Natl Acad Sci U S A 2003, 100: 12480–12485. 10.1073/pnas.2032100100PubMed CentralPubMedView ArticleGoogle Scholar
  25. Mohapatra DP, Nau C: Desensitization of capsaicin-activated currents in the vanilloid receptor TRPV1 is decreased by the cyclic AMP-dependent protein kinase pathway. J Biol Chem 2003, 278: 50080–50090. 10.1074/jbc.M306619200PubMedView ArticleGoogle Scholar
  26. Rathee PK, Distler C, Obreja O, Neuhuber W, Wang GK, Wang S-Y, Nau C, Kress M: PKA/AKAP/VR-1 module: A common link of Gs-mediated signaling to thermal hyperalgesia. J Neurosci 2002, 22: 4740–4745.PubMedGoogle Scholar
  27. Schnizler K, Shutov LP, Van Kanegan MJ, Merrill MA, Nichols B, McKnight GS, Strack S, Hell JW, Usachev YM: Protein kinase A anchoring via AKAP150 is essential for TRPV1 modulation by forskolin and prostaglandin E2 in mouse sensory neurons. J Neurosci 2008, 28: 4904–4917. 10.1523/JNEUROSCI.0233-08.2008PubMed CentralPubMedView ArticleGoogle Scholar
  28. Pan H-L, Wu Z, Zhou H-Y, Chen S, Zhang H, Li D-P: Modulation of pain transmission by G-protein-coupled receptors. Pharmacol Ther 2008, 117: 141–161. 10.1016/j.pharmthera.2007.09.003PubMed CentralPubMedView ArticleGoogle Scholar
  29. Rakhit S, Conway AM, Tate R, Bower T, Pyne NJ, Pyne S: Sphingosine 1-phosphate stimulation of the p42/p44 mitogen-activated protein kinase pathway in airway smooth muscle. Role of endothelial differentiation gene 1, c-Src tyrosine kinase and phosphoinositide 3-kinase. Biochem J 1999,338(Pt 3):643–649.PubMed CentralPubMedView ArticleGoogle Scholar
  30. Brizuela L, Rábano M, Gangoiti P, Narbona N, Macarulla JM, Trueba M, Gómez-Muñoz A: Sphingosine-1-phosphate stimulates aldosterone secretion through a mechanism involving the PI3K/PKB and MEK/ERK 1/2 pathways. J Lipid Res 2007, 48: 2264–2274. 10.1194/jlr.M700291-JLR200PubMedView ArticleGoogle Scholar
  31. Grey A, Chen Q, Callon K, Xu X, Reid IR, Cornish J: The phospholipids sphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cells via a signaling pathway involving G(i) proteins and phosphatidylinositol-3 kinase. Endocrinology 2002, 143: 4755–4763. 10.1210/en.2002-220347PubMedView ArticleGoogle Scholar
  32. Jiang G, Zhang BB: Pi 3-kinase and its up- and down-stream modulators as potential targets for the treatment of type II diabetes. Front Biosci 2002, 7: d903-d907. 10.2741/jiangPubMedView ArticleGoogle Scholar
  33. Baudhuin LM, Cristina KL, Lu J, Xu Y: Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific. Mol Pharmacol 2002, 62: 660–671. 10.1124/mol.62.3.660PubMedView ArticleGoogle Scholar
  34. Robert P, Tsui P, Laville MP, Livi GP, Sarau HM, Bril A, Berrebi-Bertrand I: EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes. J Mol Cell Cardiol 2001, 33: 1589–1606. 10.1006/jmcc.2001.1433PubMedView ArticleGoogle Scholar
  35. Spiegel S, Milstien S: The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol 2011, 11: 403–415. 10.1038/nri2974PubMed CentralPubMedView ArticleGoogle Scholar
  36. Watterson KR, Lanning DA, Diegelmann RF, Spiegel S: Regulation of fibroblast functions by lysophospholipid mediators: potential roles in wound healing. Wound Repair Regen 2007, 15: 607–616. 10.1111/j.1524-475X.2007.00292.xPubMedView ArticleGoogle Scholar
  37. Zhang YH, Vasko MR, Nicol GD: Intracellular sphingosine 1-phosphate mediates the increased excitability produced by nerve growth factor in rat sensory neurons. J Physiol 2006,575(Pt 1):101–113.PubMed CentralPubMedView ArticleGoogle Scholar
  38. Herr DR, Chun J: Effects of LPA and S1P on the nervous system and implications for their involvement in disease. Curr Drug Targets 2007, 8: 155–167. 10.2174/138945007779315669PubMedView ArticleGoogle Scholar
  39. Spiegel S, Milstien S: Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003, 4: 397–407. 10.1038/nrm1103PubMedView ArticleGoogle Scholar
  40. Rodgers A, Mormeneo D, Long JS, Delgado A, Pyne NJ, Pyne S: Sphingosine 1-phosphate regulation of extracellular signal-regulated kinase-1/2 in embryonic stem cells. Stem Cells Dev 2009, 18: 1319–1330. 10.1089/scd.2009.0023PubMedView ArticleGoogle Scholar
  41. Zhuang Z, Xu H, Clapham DE, Ji R: Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J Neurosci 2004, 24: 8300–8309. 10.1523/JNEUROSCI.2893-04.2004PubMedView ArticleGoogle Scholar
  42. Zhu W, Oxford GS: Phosphoinositide-3-kinase and mitogen activated protein kinase signaling pathways mediate acute NGF sensitization of TRPV1. Mol Cell Neurosci 2007, 34: 689–700. 10.1016/j.mcn.2007.01.005PubMed CentralPubMedView ArticleGoogle Scholar
  43. Zhang X, Huang J, McNaughton PA: NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J 2005, 24: 4211–4223. 10.1038/sj.emboj.7600893PubMed CentralPubMedView ArticleGoogle Scholar
  44. Saudemont A, Garçon F, Yadi H, Roche-Molina M, Kim N, Segonds-Pichon A, Martín-Fontecha A, Okkenhaug K, Colucci F: p110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease. Proc Natl Acad Sci U S A 2009, 106: 5795–5800. 10.1073/pnas.0808594106PubMed CentralPubMedView ArticleGoogle Scholar
  45. Han Y, Li Y, Xiao X, Liu J, Meng X-L, Liu F-Y, Xing G-G, Wan Y: Formaldehyde up-regulates TRPV1 through MAPK and PI3K signaling pathways in a rat model of bone cancer pain. Neurosci Bull 2012, 28: 165–172. 10.1007/s12264-012-1211-0PubMedView ArticleGoogle Scholar
  46. Guillermet-Guibert J, Bjorklof K, Salpekar A, Gonella C, Ramadani F, Bilancio A, Meek S, Smith AJH, Okkenhaug K, Vanhaesebroeck B: The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. Proc Natl Acad Sci U S A 2008, 105: 8292–8297. 10.1073/pnas.0707761105PubMed CentralPubMedView ArticleGoogle Scholar
  47. Malchinkhuu E, Sato K, Horiuchi Y, Mogi C, Ohwada S, Ishiuchi S, Saito N, Kurose H, Tomura H, Okajima F: Role of p38 mitogen-activated kinase and c-Jun terminal kinase in migration response to lysophosphatidic acid and sphingosine-1-phosphate in glioma cells. Oncogene 2005, 24: 6676–6688. 10.1038/sj.onc.1208805PubMedView ArticleGoogle Scholar
  48. Widmann C, Gibson S, Jarpe MB, Johnson GL: Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 1999, 79: 143–180.PubMedGoogle Scholar
  49. Shi Y, Gaestel M: In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance. Biol Chem 2002, 383: 1519–1536.PubMedView ArticleGoogle Scholar
  50. Jin S-X, Zhuang Z-Y, Woolf CJ, Ji R-R: P38 Mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 2003, 23: 4017–4022.PubMedGoogle Scholar
  51. Ji R-R, Suter MR: p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 2007, 3: 33. 10.1186/1744-8069-3-33PubMed CentralPubMedView ArticleGoogle Scholar
  52. Donnerer J, Liebmann I: A fluorescence-immunohistochemical study on phosphorylation of ERK1/2, p38, and STAT3 in rat dorsal root ganglia following noxious stimulation of hind paw sensory neurons. Tissue Cell 2011, 43: 178–189. 10.1016/j.tice.2011.02.002PubMedView ArticleGoogle Scholar
  53. Hudmon A, Choi J-S, Tyrrell L, Black JA, Rush AM, Waxman SG, Dib-Hajj SD: Phosphorylation of sodium channel Na(v)1.8 by p38 mitogen-activated protein kinase increases current density in dorsal root ganglion neurons. J Neurosci 2008, 28: 3190–3201. 10.1523/JNEUROSCI.4403-07.2008PubMedView ArticleGoogle Scholar
  54. Zang Y, Xin W-J, Pang R-P, Li Y-Y, Liu X-G: Upregulation of Nav1.3 Channel Induced by rrTNF in Cultured Adult Rat DRG Neurons via p38 MAPK and JNK Pathways. Chin J Physiol 2011, 54: 241–246. 10.4077/CJP.2011.AMM075PubMedView ArticleGoogle Scholar
  55. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D: The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998, 21: 531–543. 10.1016/S0896-6273(00)80564-4PubMedView ArticleGoogle Scholar
  56. Mandadi S, Tominaga T, Numazaki M, Murayama N, Saito N, Armati PJ, Roufogalis BD, Tominaga M: Increased sensitivity of desensitized TRPV1 by PMA occurs through PKCepsilon-mediated phosphorylation at S800. Pain 2006, 123: 106–116. 10.1016/j.pain.2006.02.016PubMedView ArticleGoogle Scholar
  57. Tang H-B, Li Y-S, Miyano K, Nakata Y: Phosphorylation of TRPV1 by neurokinin-1 receptor agonist exaggerates the capsaicin-mediated substance P release from cultured rat dorsal root ganglion neurons. Neuropharmacology 2008, 55: 1405–1411. 10.1016/j.neuropharm.2008.08.037PubMedView ArticleGoogle Scholar
  58. Obreja O, Biasio W, Andratsch M, Lips KS, Rathee PK, Ludwig A, Rose-John S, Kress M: Fast modulation of heat-activated ionic current by proinflammatory interleukin 6 in rat sensory neurons. Brain 2005,128(Pt 7):1634–1641.PubMedView ArticleGoogle Scholar
  59. Langeslag M, Malsch P, Welling A, Kress M: Reduced excitability of gp130-deficient nociceptors is associated with increased voltage-gated potassium currents and Kcna4 channel upregulation. Pflugers Arch 2014, 446: 2153–2165.View ArticleGoogle Scholar

Copyright

© Langeslag et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement